List of Tables
Table 1. Global Infliximab Injection Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Infliximab Injection Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Infliximab Injection Market Competitive Situation by Manufacturers in 2025
Table 4. Global Infliximab Injection Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Infliximab Injection Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Infliximab Injection Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Infliximab Injection Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Infliximab Injection Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Infliximab Injection, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Infliximab Injection, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Infliximab Injection, Product Types and Applications
Table 12. Global Key Manufacturers of Infliximab Injection, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Infliximab Injection Companies by Tier (Tier 1, Tier 2, Tier 3), based on Infliximab Injection Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Infliximab Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Infliximab Injection Sales by Region (K Units), 2021–2026
Table 18. Global Infliximab Injection Sales Market Share by Region (2021–2026)
Table 19. Global Infliximab Injection Sales by Region (K Units), 2027–2032
Table 20. Global Infliximab Injection Sales Market Share by Region (2027–2032)
Table 21. Global Infliximab Injection Revenue by Region (US$ Million), 2021–2026
Table 22. Global Infliximab Injection Revenue Market Share by Region (2021–2026)
Table 23. Global Infliximab Injection Revenue by Region (US$ Million), 2027–2032
Table 24. Global Infliximab Injection Revenue Market Share by Region (2027–2032)
Table 25. North America Infliximab Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Infliximab Injection Sales by Country (K Units), 2021–2026
Table 27. North America Infliximab Injection Sales by Country (K Units), 2027–2032
Table 28. North America Infliximab Injection Revenue by Country (US$ Million), 2021–2026
Table 29. North America Infliximab Injection Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Infliximab Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Infliximab Injection Sales by Country (K Units), 2021–2026
Table 32. Europe Infliximab Injection Sales by Country (K Units), 2027–2032
Table 33. Europe Infliximab Injection Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Infliximab Injection Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Infliximab Injection Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Infliximab Injection Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Infliximab Injection Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Infliximab Injection Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Infliximab Injection Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Infliximab Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Infliximab Injection Sales by Country (K Units), 2021–2026
Table 42. Latin America Infliximab Injection Sales by Country (K Units), 2027–2032
Table 43. Latin America Infliximab Injection Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Infliximab Injection Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Infliximab Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Infliximab Injection Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Infliximab Injection Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Infliximab Injection Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Infliximab Injection Revenue by Country (US$ Million), 2027–2032
Table 50. Global Infliximab Injection Sales (K Units) by Type (2021–2026)
Table 51. Global Infliximab Injection Sales (K Units) by Type (2027–2032)
Table 52. Global Infliximab Injection Sales Market Share by Type (2021–2026)
Table 53. Global Infliximab Injection Sales Market Share by Type (2027–2032)
Table 54. Global Infliximab Injection Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Infliximab Injection Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Infliximab Injection Revenue Market Share by Type (2021–2026)
Table 57. Global Infliximab Injection Revenue Market Share by Type (2027–2032)
Table 58. Global Infliximab Injection Price (US$/Unit) by Type (2021–2026)
Table 59. Global Infliximab Injection Price (US$/Unit) by Type (2027–2032)
Table 60. Global Infliximab Injection Sales (K Units) by Application (2021–2026)
Table 61. Global Infliximab Injection Sales (K Units) by Application (2027–2032)
Table 62. Global Infliximab Injection Sales Market Share by Application (2021–2026)
Table 63. Global Infliximab Injection Sales Market Share by Application (2027–2032)
Table 64. Global Infliximab Injection Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Infliximab Injection Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Infliximab Injection Revenue Market Share by Application (2021–2026)
Table 67. Global Infliximab Injection Revenue Market Share by Application (2027–2032)
Table 68. Global Infliximab Injection Price (US$/Unit) by Application (2021–2026)
Table 69. Global Infliximab Injection Price (US$/Unit) by Application (2027–2032)
Table 70. Celltrion Company Information
Table 71. Celltrion Description and Business Overview
Table 72. Celltrion Infliximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Celltrion Infliximab Injection Product
Table 74. Celltrion Recent Developments/Updates
Table 75. Janssen Biologics Company Information
Table 76. Janssen Biologics Description and Business Overview
Table 77. Janssen Biologics Infliximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Janssen Biologics Infliximab Injection Product
Table 79. Janssen Biologics Recent Developments/Updates
Table 80. Hangzhou Bozhirui Biopharmaceuticals Company Information
Table 81. Hangzhou Bozhirui Biopharmaceuticals Description and Business Overview
Table 82. Hangzhou Bozhirui Biopharmaceuticals Infliximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Hangzhou Bozhirui Biopharmaceuticals Infliximab Injection Product
Table 84. Hangzhou Bozhirui Biopharmaceuticals Recent Developments/Updates
Table 85. Taizhou Maiboteike Pharmaceuticals Company Information
Table 86. Taizhou Maiboteike Pharmaceuticals Description and Business Overview
Table 87. Taizhou Maiboteike Pharmaceuticals Infliximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Taizhou Maiboteike Pharmaceuticals Infliximab Injection Product
Table 89. Taizhou Maiboteike Pharmaceuticals Recent Developments/Updates
Table 90. Yuxi Jiahe Biotechnology Company Information
Table 91. Yuxi Jiahe Biotechnology Description and Business Overview
Table 92. Yuxi Jiahe Biotechnology Infliximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Yuxi Jiahe Biotechnology Infliximab Injection Product
Table 94. Yuxi Jiahe Biotechnology Recent Developments/Updates
Table 95. Ayumi Pharmaceuticals Company Information
Table 96. Ayumi Pharmaceuticals Description and Business Overview
Table 97. Ayumi Pharmaceuticals Infliximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Ayumi Pharmaceuticals Infliximab Injection Product
Table 99. Ayumi Pharmaceuticals Recent Developments/Updates
Table 100. Pfizer Company Information
Table 101. Pfizer Description and Business Overview
Table 102. Pfizer Infliximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Pfizer Infliximab Injection Product
Table 104. Pfizer Recent Developments/Updates
Table 105. Nichiiko Company Information
Table 106. Nichiiko Description and Business Overview
Table 107. Nichiiko Infliximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Nichiiko Infliximab Injection Product
Table 109. Nichiiko Recent Developments/Updates
Table 110. Nippon Kayaku Company Information
Table 111. Nippon Kayaku Description and Business Overview
Table 112. Nippon Kayaku Infliximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Nippon Kayaku Infliximab Injection Product
Table 114. Nippon Kayaku Recent Developments/Updates
Table 115. AMGEN Company Information
Table 116. AMGEN Description and Business Overview
Table 117. AMGEN Infliximab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. AMGEN Infliximab Injection Product
Table 119. AMGEN Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Infliximab Injection Distributors List
Table 123. Infliximab Injection Customers List
Table 124. Infliximab Injection Market Trends
Table 125. Infliximab Injection Market Drivers
Table 126. Infliximab Injection Market Challenges
Table 127. Infliximab Injection Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of Infliximab Injection
Figure 2. Global Infliximab Injection Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Infliximab Injection Market Share by Type: 2025 & 2032
Figure 4. Original Drug Product Picture
Figure 5. Generic Drug Product Picture
Figure 6. Global Infliximab Injection Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Infliximab Injection Market Share by Application: 2025 & 2032
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Other
Figure 11. Global Infliximab Injection Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Infliximab Injection Market Size (US$ Million), 2021–2032
Figure 13. Global Infliximab Injection Sales (K Units), 2021–2032
Figure 14. Global Infliximab Injection Average Price (US$/Unit), 2021–2032
Figure 15. Infliximab Injection Report Years Considered
Figure 16. Infliximab Injection Sales Share by Manufacturers in 2025
Figure 17. Global Infliximab Injection Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Infliximab Injection Players: Market Share by Revenue in Infliximab Injection in 2025
Figure 19. Infliximab Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Infliximab Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Infliximab Injection Sales Market Share by Country (2021–2032)
Figure 22. North America Infliximab Injection Revenue Market Share by Country (2021–2032)
Figure 23. United States Infliximab Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Infliximab Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Infliximab Injection Sales Market Share by Country (2021–2032)
Figure 26. Europe Infliximab Injection Revenue Market Share by Country (2021–2032)
Figure 27. Germany Infliximab Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Infliximab Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Infliximab Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Infliximab Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Infliximab Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Infliximab Injection Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Infliximab Injection Revenue Market Share by Region (2021–2032)
Figure 34. China Infliximab Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Infliximab Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Infliximab Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Infliximab Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Infliximab Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Infliximab Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Infliximab Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Infliximab Injection Sales Market Share by Country (2021–2032)
Figure 42. Latin America Infliximab Injection Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Infliximab Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Infliximab Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Infliximab Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Infliximab Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Infliximab Injection Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Infliximab Injection Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Infliximab Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Infliximab Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Infliximab Injection Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Infliximab Injection by Type (2021–2032)
Figure 53. Global Revenue Market Share of Infliximab Injection by Type (2021–2032)
Figure 54. Global Infliximab Injection Price (US$/Unit) by Type (2021–2032)
Figure 55. Global Sales Market Share of Infliximab Injection by Application (2021–2032)
Figure 56. Global Revenue Market Share of Infliximab Injection by Application (2021–2032)
Figure 57. Global Infliximab Injection Price (US$/Unit) by Application (2021–2032)
Figure 58. Infliximab Injection Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
